Broadcom Corp. PT Lowered to $35.00 (BRCM) (Zolmax) Equities research analysts at Canaccord Genuity decreased their target price on shares of Broadcom Corporation (NASDAQ: BRCM ) from $40.00 to $35.00 in a research note issued to investors on Thursday, American Banking and Market News reports. The firm currently has a "buy" rating on the stock. Canaccord Genuity's price objective would suggest a potential upside of 30.50% from the stock's previous close. Broadcom Corporation (NASDAQ:BRCM) traded up 3.47% during mid-day trading on Thursday, hitting $26.82. 22,799,740 shares of the company's stock traded hands. Qualcomm's 2net Mobile to Provide HIPAA Certified Secure Medical Connectivity (HealthTechZone) Telemedicine will usher in a host of services designed to give patients with chronic disorders real-time diagnoses of their conditions.